
Announcement Date for 2024 Full Year Results
Dublin, London, 06 February 2025: Greencoat Renewables PLC ("Greencoat Renewables" or the "Company") will release Full Year Results for the year to 31 December 2024, on Thursday, 06 March 2025.
A webcast and conference call for analysts and investors will be held at 09.00 am GMT on the day. To register please contact FTI Consulting by email at greencoat@fticonsulting.com.
The Company's Full Year Results Press Release and Presentation will be available on the Greencoat Renewables website at 07.00 am GMT on 06 March 2025 at www.greencoat-renewables.com.
--- ENDS ---
āFor further information on the Announcement, please contact:
Schroders Greencoat LLP (Investment Manager) | | | | | | |
Bertrand Gautier Paul O'Donnell John Musk | | | | | +44 20 7832 9400 | |
FTI Consulting (Investor Relations & Media) | | | | |
| |
Sam Moore | | | | | +353 87 737 9089 | |
Aoife Mullen | | | | | | |
Barclays Bank PLC (Joint Broker) Dion Di Miceli Stuart Muress James Atkinson | | | | |
+44 20 7623 2323 | |
Davy (Broker, NOMAD and Euronext Growth Listing Sponsor) Brian Garrahy Ronan Veale | | | | |
+353 1 679 6363
| |
RBC Capital Markets (Joint Broker) Matthew Coakes Elizabeth Evans | | | | |
+44 20 7653 4000 | |
āAbout Greencoat Renewables PLC
Greencoat Renewables PLC is an investor in euro-denominated renewable energy infrastructure assets. Initially focused solely on the acquisition and management of operating wind farms in Ireland, the Company is now also investing in wind and solar assets in other European countries with stable and robust renewable energy frameworks. It is managed by Schroders Greencoat LLP, an experienced investment manager in the listed renewable energy infrastructure sector.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.